Cozzi P - Search Results

1

Monitoring Prostate Tumor Growth in an Orthotopic Mouse Model Using Three-Dimensional Ultrasound Imaging Technique.

Ni J, Cozzi P, Hung TT, Hao J, Graham P, Li Y. Ni J, et al. Among authors: cozzi p. Transl Oncol. 2016 Feb;9(1):41-45. doi: 10.1016/j.tranon.2015.11.011. Transl Oncol. 2016. PMID: 26947880 Free PMC article.

2

Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.

Ni J, Cozzi P, Hao J, Beretov J, Chang L, Duan W, Shigdar S, Delprado W, Graham P, Bucci J, Kearsley J, Li Y. Ni J, et al. Among authors: cozzi p. Int J Biochem Cell Biol. 2013 Dec;45(12):2736-48. doi: 10.1016/j.biocel.2013.09.008. Epub 2013 Sep 25. Int J Biochem Cell Biol. 2013. PMID: 24076216

3

Cancer stem cells in prostate cancer chemoresistance.

Ni J, Cozzi P, Hao J, Duan W, Graham P, Kearsley J, Li Y. Ni J, et al. Among authors: cozzi p. Curr Cancer Drug Targets. 2014;14(3):225-40. doi: 10.2174/1568009614666140328152459. Curr Cancer Drug Targets. 2014. PMID: 24720286

4

Urinary biomarkers in prostate cancer detection and monitoring progression.

Wu D, Ni J, Beretov J, Cozzi P, Willcox M, Wasinger V, Walsh B, Graham P, Li Y. Wu D, et al. Among authors: cozzi p. Crit Rev Oncol Hematol. 2017 Oct;118:15-26. doi: 10.1016/j.critrevonc.2017.08.002. Epub 2017 Aug 19. Crit Rev Oncol Hematol. 2017. PMID: 28917266 Review.

5

Epithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo.

Ni J, Cozzi P, Beretov J, Duan W, Bucci J, Graham P, Li Y. Ni J, et al. Among authors: cozzi p. BMC Cancer. 2018 Nov 12;18(1):1092. doi: 10.1186/s12885-018-5010-5. BMC Cancer. 2018. PMID: 30419852 Free PMC article.

6

Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance.

Chang L, Graham PH, Hao J, Ni J, Bucci J, Cozzi PJ, Kearsley JH, Li Y. Chang L, et al. Among authors: cozzi pj. Cell Death Dis. 2013 Oct 24;4(10):e875. doi: 10.1038/cddis.2013.407. Cell Death Dis. 2013. PMID: 24157869 Free PMC article.

7

Angiogenesis as a strategic target for prostate cancer therapy.

Li Y, Cozzi PJ. Li Y, et al. Med Res Rev. 2010 Jan;30(1):23-66. doi: 10.1002/med.20161. Med Res Rev. 2010. PMID: 19536866 Review.

8

Role of the EpCAM (CD326) in prostate cancer metastasis and progression.

Ni J, Cozzi PJ, Duan W, Shigdar S, Graham PH, John KH, Li Y. Ni J, et al. Cancer Metastasis Rev. 2012 Dec;31(3-4):779-91. doi: 10.1007/s10555-012-9389-1. Cancer Metastasis Rev. 2012. PMID: 22718399 Review.

9

In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147.

Hao J, Madigan MC, Khatri A, Power CA, Hung TT, Beretov J, Chang L, Xiao W, Cozzi PJ, Graham PH, Kearsley JH, Li Y. Hao J, et al. PLoS One. 2012;7(8):e40716. doi: 10.1371/journal.pone.0040716. Epub 2012 Aug 3. PLoS One. 2012. PMID: 22870202 Free PMC article.

10

CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance.

Ni J, Cozzi PJ, Hao JL, Beretov J, Chang L, Duan W, Shigdar S, Delprado WJ, Graham PH, Bucci J, Kearsley JH, Li Y. Ni J, et al. Prostate. 2014 May;74(6):602-17. doi: 10.1002/pros.22775. Epub 2014 Feb 12. Prostate. 2014. PMID: 24615685

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

243 results

Search Page

Filters